Regulation of the Warburg Effect in Cancer
癌症中瓦尔堡效应的调节
基本信息
- 批准号:8146230
- 负责人:
- 金额:$ 231万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-30 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntineoplastic AgentsDrug Delivery SystemsMaintenanceMalignant NeoplasmsMetabolismMolecularNormal CellOxidative PhosphorylationOxygenProductionRegulationResearchRoleTestingTherapeuticWarburg Effectabstractingaerobic glycolysiscancer cellcancer therapyin vivoneoplastic cellnovelpublic health relevancetumor growthtumorigenesis
项目摘要
DESCRIPTION (Provided by the applicant)
Abstract: The metabolism of cancer cells is different from that of their normal cell counterparts. Known as the Warburg effect (or aerobic glycolysis), this altered tumor cell metabolism is characterized by enhanced lactate production with reduced oxidative phosphorylation even in the presence of oxygen. Although this observation was first made over 75 years ago, how cancer cells establish this altered metabolism and whether it is important for tumorigenesis remains unknown. Our research aims to determine the molecular mechanisms by which tumor cells establish and maintain the Warburg effect in cancer, to definitively address whether the Warburg effect is necessary for tumor growth, and to identify novel cancer drug targets responsible for maintenance of the Warburg effect in vivo. This study will determine whether targeting cancer metabolism is a viable approach for cancer therapy and will better define the role of metabolism for tumor growth.
Public Health Relevance: This proposed research will investigate causes of the altered metabolism found in cancer cells. It will also test whether targeting this altered metabolism is a viable strategy for cancer therapeutics.
描述(由申请人提供)
翻译后摘要:癌细胞的代谢是不同的,从他们的正常细胞对应。这种改变的肿瘤细胞代谢被称为瓦尔堡效应(或有氧糖酵解),其特征在于即使在氧气存在下,乳酸产生也会增加,氧化磷酸化也会减少。尽管这一观察是在75年前首次进行的,但癌细胞如何建立这种改变的代谢以及它对肿瘤发生是否重要仍然是未知的。我们的研究旨在确定肿瘤细胞在癌症中建立和维持瓦尔堡效应的分子机制,以明确瓦尔堡效应是否是肿瘤生长所必需的,并确定负责维持体内瓦尔堡效应的新型癌症药物靶点。这项研究将确定靶向癌症代谢是否是一种可行的癌症治疗方法,并将更好地定义代谢对肿瘤生长的作用。
公共卫生相关性:这项拟议的研究将调查癌细胞中发现的代谢改变的原因。它还将测试靶向这种改变的代谢是否是癌症治疗的可行策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather Christofk其他文献
Heather Christofk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heather Christofk', 18)}}的其他基金
Metabolic Control of Hair Follicle Stem Cell Homeostasis and Tumorigenesis
毛囊干细胞稳态和肿瘤发生的代谢控制
- 批准号:
9883715 - 财政年份:2018
- 资助金额:
$ 231万 - 项目类别:
Metabolic Control of Hair Follicle Stem Cell Homeostasis and Tumorigenesis
毛囊干细胞稳态和肿瘤发生的代谢控制
- 批准号:
10361228 - 财政年份:2018
- 资助金额:
$ 231万 - 项目类别:
Molecular Imaging of Metabolic Switches in Malignant Transformations
恶性转化中代谢开关的分子成像
- 批准号:
7983563 - 财政年份:2010
- 资助金额:
$ 231万 - 项目类别:
Molecular Imaging of Metabolic Switches in Malignant Transformations
恶性转化中代谢开关的分子成像
- 批准号:
8545710 - 财政年份:
- 资助金额:
$ 231万 - 项目类别:
Molecular Imaging of Metabolic Switches in Malignant Transformations
恶性转化中代谢开关的分子成像
- 批准号:
8324026 - 财政年份:
- 资助金额:
$ 231万 - 项目类别:
Molecular Imaging of Metabolic Switches in Malignant Transformations
恶性转化中代谢开关的分子成像
- 批准号:
8380719 - 财政年份:
- 资助金额:
$ 231万 - 项目类别:
Molecular Imaging of Metabolic Switches in Malignant Transformations
恶性转化中代谢开关的分子成像
- 批准号:
8707989 - 财政年份:
- 资助金额:
$ 231万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 231万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 231万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 231万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 231万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 231万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 231万 - 项目类别: